Subscribe
Subscribe
Home Tags Alzheimer's

Tag: Alzheimer's

Thankfully, the scientific community isn't taking the FDA's non-scientific approach to kratom lying down. (AP Photo/Andrew Harnik)
Healthcare

FDA head invites investigation into agency contact with manufacturer of controversial Alzheimer’s treatment

Cassidy Morrison -
0
FDA narrows eligibility for controversial $56,000 Alzheimer’s treatment
Healthcare

FDA narrows eligibility for controversial $56,000 Alzheimer’s treatment

Cassidy Morrison -
0
In cost-saving move, Medicare could limit patient access to Alzheimer’s treatment
Healthcare

In cost-saving move, Medicare could limit patient access to Alzheimer’s treatment

Cassidy Morrison -
0
U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
Healthcare

Controversial Alzheimer’s drug a godsend for a trial participant, but price tag could put it out of reach

Cassidy Morrison -
0
Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval
Healthcare

Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval

Cassidy Morrison -
0
Approval of controversial $56,000 Alzheimer’s treatment could add $57 billion to federal spending
Healthcare

Approval of controversial $56,000 Alzheimer’s treatment could add $57 billion to federal spending

Cassidy Morrison -
0
Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug
Healthcare

Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug

Cassidy Morrison -
0
There is little research on the causes of Alzheimer’s, according to a recent report from the Food and Drug Administration. (AP file)
Healthcare

Scientists discover potentially dangerous metals in brains of Alzheimer’s patients

David Hogberg -
0
FILE - This undated file combo image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. Researchers said an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease. (AP Photo/Merck & Co., File)
Healthcare

FDA approves Alzheimer’s drug despite controversy over effectiveness

David Hogberg -
0
Healthcare

Biden pitches creation of high-risk, high-reward disease research division with a massive budget

Cassidy Morrison -
0
1...3456Page 4 of 6
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA